Am. J. Respir. Crit. Care Med., Volume 162, Number 4, October 2000, 1277-1284

An Investigation into Causative Factors in Patients with Bronchiectasis

MARK C. PASTEUR, SHARON M. HELLIWELL, SALLY J. HOUGHTON, SUSANNAH C. WEBB, JULIET E. FOWERAKER, RICHARD A. COULDEN, CHRISTOPHER D. FLOWER, DIANA BILTON, and MARY T. KEOGAN

Lung Defence Unit, Department of Immunology, Department of Microbiology, and Department of Radiology, Papworth Hospital, Cambridge, United Kingdom

Bronchiectasis is a pathologic description of lung damage characterized by inflamed and dilated thick-walled bronchi. These findings may result from a number of possible causes and these may influence treatment and prognosis. The aim of this study was to determine causative factors in 150 adults with bronchiectasis (56 male, 94 female) identified using high-resolution computerized tomography. Relevant factors were identified in the clinical history; cystic fibrosis gene mutation analysis was performed; humoral immune defects were determined by measuring immunoglobulins, IgG subclasses and functional response to Pneumovax II vaccine; assessment was made of neutrophil function (respiratory burst, adhesion molecule expression, and chemotaxis); ciliary function was observed and those likely to have allergic bronchopulmonary aspergillosis (ABPA) were identified. Causes identified were: immune defects (12 cases), cystic fibrosis (), Young's syndrome (), ciliary dysfunction (), aspiration (), panbronchiolitis (), congenital defect (), ABPA (), rheumatoid arthritis (), and early childhood pneumonia, pertussis, or measles (). Intensive investigation of this population of patients with bronchiectasis led to identification of one or more causative factor in 47% of cases. In 22 patients (15%), the cause identified had implications for prognosis and treatment.

This article has been cited by other articles:

				A. E. O'Donnell Bronchiectasis Chest, October 1, 2008; 134(4): 815 - 823. [Abstract] [Full Text] [PDF]

				A B Chang and D Bilton Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis Thorax, March 1, 2008; 63(3): 269 - 276. [Abstract] [Full Text] [PDF]

				S. Fuschillo, A. De Felice, and G. Balzano Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Eur. Respir. J., February 1, 2008; 31(2): 396 - 406. [Abstract] [Full Text] [PDF]

				D. G. Parr, P. G. Guest, J. H. Reynolds, L. J. Dowson, and R. A. Stockley Prevalence and Impact of Bronchiectasis in {alpha}1-Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1215 - 1221. [Abstract] [Full Text] [PDF]

				N. H T t. Hacken, P. J Wijkstra, and H. A M Kerstjens Treatment of bronchiectasis in adults BMJ, November 24, 2007; 335(7629): 1089 - 1093. [Full Text] [PDF]

				J S Elborn and S C Bell Pulmonary exacerbations in cystic fibrosis and bronchiectasis Thorax, April 1, 2007; 62(4): 288 - 290. [Full Text] [PDF]

				D. Donnelly, A. Critchlow, and M. L Everard Outcomes in children treated for persistent bacterial bronchitis Thorax, January 1, 2007; 62(1): 80 - 84. [Abstract] [Full Text] [PDF]

				S. J. Fowler, J. French, N. J. Screaton, J. Foweraker, A. Condliffe, C. S. Haworth, A. R. Exley, and D. Bilton Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Eur. Respir. J., December 1, 2006; 28(6): 1204 - 1210. [Abstract] [Full Text] [PDF]

				D. Bilton, N. Henig, B. Morrissey, and M. Gotfried Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis. Chest, November 1, 2006; 130(5): 1503 - 1510. [Abstract] [Full Text] [PDF]

				T. M. Ziedalski, P. N. Kao, N. R. Henig, S. S. Jacobs, and S. J. Ruoss Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest, October 1, 2006; 130(4): 995 - 1002. [Abstract] [Full Text] [PDF]

				F. Santamaria, S. Montella, L. Camera, C. Palumbo, L. Greco, and A. L. Boner Lung structure abnormalities, but normal lung function in pediatric bronchiectasis. Chest, August 1, 2006; 130(2): 480 - 486. [Abstract] [Full Text] [PDF]

				W-J Koh, O J Kwon, R Wilson, M Wickremasinghe, L J Ozerovitch, G Davies, T Wodehouse, M V Chadwick, S Abdallah, and P Shah Bronchiectasis and non-tuberculous mycobacterial pulmonary infection * Authors' reply Thorax, May 1, 2006; 61(5): 458 - 458. [Full Text] [PDF]

				J Twiss, A W Stewart, and C A Byrnes Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis Thorax, May 1, 2006; 61(5): 414 - 418. [Abstract] [Full Text] [PDF]

				H. Yarmohammadi, L. Estrella, J. Doucette, and C. Cunningham-Rundles Recognizing primary immune deficiency in clinical practice. Clin. Vaccine Immunol., March 1, 2006; 13(3): 329 - 332. [Abstract] [Full Text] [PDF]

				M. J. Rosen Chronic Cough Due to Bronchiectasis: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 122S - 131S. [Abstract] [Full Text] [PDF]

				M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]

				M Wickremasinghe, L J Ozerovitch, G Davies, T Wodehouse, M V Chadwick, S Abdallah, P Shah, and R Wilson Non-tuberculous mycobacteria in patients with bronchiectasis Thorax, December 1, 2005; 60(12): 1045 - 1051. [Abstract] [Full Text] [PDF]

				A. M. Li, S. Sonnappa, C. Lex, E. Wong, A. Zacharasiewicz, A. Bush, and A. Jaffe Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur. Respir. J., July 1, 2005; 26(1): 8 - 14. [Abstract] [Full Text] [PDF]

				J Twiss, R Metcalfe, E Edwards, and C Byrnes New Zealand national incidence of bronchiectasis "too high" for a developed country Arch. Dis. Child., July 1, 2005; 90(7): 737 - 740. [Abstract] [Full Text] [PDF]

				P. Scheinberg, E. Shore, and on behalf of the PC-TNDS-008 Study Group A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis Chest, April 1, 2005; 127(4): 1420 - 1426. [Abstract] [Full Text] [PDF]

				D. A. van Kessel, H. van Velzen-Blad, J. M. M. van den Bosch, and G. T. Rijkers Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology Eur. Respir. J., March 1, 2005; 25(3): 482 - 489. [Abstract] [Full Text] [PDF]

				K W Tsang, K C Tan, P L Ho, G C Ooi, J C Ho, J Mak, G L Tipoe, C Ko, C Yan, W K Lam, et al. Inhaled fluticasone in bronchiectasis: a 12 month study Thorax, March 1, 2005; 60(3): 239 - 243. [Abstract] [Full Text] [PDF]

				M. Vendrell, J. de Gracia, M.-J. Rodrigo, M.-J. Cruz, A. Alvarez, M. Garcia, and M. Miravitlles Antibody Production Deficiency With Normal IgG Levels in Bronchiectasis of Unknown Etiology Chest, January 1, 2005; 127(1): 197 - 204. [Abstract] [Full Text] [PDF]

				M. Pifferi, A.M. Cangiotti, D. Caramella, A. Pietrobelli, V. Ragazzo, E. De Marco, P. Macchia, S. Cinti, and A.L. Boner "Cyst-like" structures within the ciliary shafts in children with bronchiectasis Eur. Respir. J., June 1, 2004; 23(6): 857 - 860. [Abstract] [Full Text] [PDF]

				M. Dupont, A. Gacouin, H. Lena, S. Lavoue, G. Brinchault, P. Delaval, and R. Thomas Survival of Patients With Bronchiectasis After the First ICU Stay for Respiratory Failure Chest, May 1, 2004; 125(5): 1815 - 1820. [Abstract] [Full Text] [PDF]

				K M Eastham, A J Fall, L Mitchell, and D A Spencer The need to redefine non-cystic fibrosis bronchiectasis in childhood Thorax, April 1, 2004; 59(4): 324 - 327. [Abstract] [Full Text] [PDF]

				P T King, N J Freezer, P W Holmes, S R Holdsworth, K Forshaw, and D D Sart Role of CFTR mutations in adult bronchiectasis Thorax, April 1, 2004; 59(4): 357 - 358. [Full Text] [PDF]

				Management of bronchiectasis DTB, December 1, 2003; 41(12): 91 - 96. [Abstract] [Full Text] [PDF]

				P. T. King, P. E. Hutchinson, P. D. Johnson, P. W. Holmes, N. J. Freezer, and S. R. Holdsworth Adaptive Immunity to Nontypeable Haemophilus influenzae Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 587 - 592. [Abstract] [Full Text] [PDF]

				E. Escudier, M. Couprie, B. Duriez, F. Roudot-Thoraval, M.-C. Millepied, V. Pruliere-Escabasse, L. Labatte, and A. Coste Computer-assisted Analysis Helps Detect Inner Dynein Arm Abnormalities Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1257 - 1262. [Abstract] [Full Text] [PDF]

				An unusual complication of ulcerative colitis Postgrad. Med. J., August 1, 2002; 78(922): 507 - 507. [Full Text] [PDF]

				R. S. Irwin and J. M. Madison The Persistently Troublesome Cough Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1469 - 1474. [Full Text] [PDF]

				A. F. Barker Bronchiectasis N. Engl. J. Med., May 2, 2002; 346(18): 1383 - 1393. [Full Text] [PDF]

				J Angrill, C Agusti, R de Celis, A Rano, J Gonzalez, T Sole, A Xaubet, R Rodriguez-Roisin, and A Torres Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors Thorax, January 1, 2002; 57(1): 15 - 19. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]